Concepedia

Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes

Alaa S. Awad, Michael Rouse, Konstantine Khutsishvili, Liping Huang, W. Kline Bolton, Kevin R. Lynch, Mark D. Okusa

Kidney International · 2011 · 92 citations · 38 references

DOIFull text

Open access

Concepts

References

38

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

, , +14

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

, , +17

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

, , +17

Podocyte loss and progressive glomerular injury in type II diabetes.

Maria Enrica Pagtalunan, Paul L. Miller, S Jumping-Eagle et al. · Journal of Clinical Investigation · 1997 · 1.1K citations · Full text

, , +17

Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate

Menq-Jer Lee, Shobha Thangada, Kevin P. Claffey et al. · Cell · 1999 · 1K citations · Full text

, , +12